Riskpilot← Back to searchSign inGet full accessDylan & Sara AB
ABActiveOrg 5593459083Åkersgränd 3Computer programming activities · NACE 6210Est. 20211 employees
Revenue 2025
SEK 971K
-11% vs 2024
EBITDA margin
12.9%
-63% vs 2024
Equity ratio
69.0%
Financial strength
Net profit 2025
SEK 19K
-90% vs 2024
| Revenue | SEK 971K | -11% |
| EBITDA | SEK 125K | -63% |
| Net profit | SEK 19K | -90% |
| Total assets | SEK 974K | -6% |
| Equity | SEK 672K | +3% |
| Employees | 1 | — |
Legal name
Dylan & Sara AB
Org number
5593459083
Legal form
Aktiebolag
NACE code
6210 · Computer programming activities
Founded
12 november 2021
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva verksamhet inom medicinsk vård, till exempel genom läkartjänster inom öppen- såväl som slutenvård, konsultverksamhet, forskning, utveckling och utbildning. Bolaget skall även bedriva produktutveckling och konsultverksamhet inom området IT, förvaltning av bolagets kapital samt därmed förenlig verksamhet.
Address
Åkersgränd 3
Email
dylan.maenpaa@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 749 | 1 251 | 1 094 | 971 |
| Staff expenses | −391 | −771 | −715 | −779 |
| EBITDA | 260 | 383 | 341 | 125 |
| Depreciation & amort. | — | −88 | −106 | −106 |
| EBIT | 260 | 295 | 236 | 20 |
| Net financials | 0 | 2 | −1 | 4 |
| Profit before tax | 260 | 297 | 235 | 24 |
| Tax | −55 | −61 | −48 | −5 |
| Net profit | 206 | 236 | 187 | 19 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 580 | 1 184 | 1 039 | 974 |
| Equity | 231 | 466 | 653 | 672 |
| Long-term debt | — | — | — | — |
| Short-term debt | 349 | 718 | 386 | 302 |
| Total debt | 349 | 718 | 386 | 302 |
EBITDA margin
12.9%
This company
15.8%
Market median
-18% vs market
20222025
Equity ratio
69.0%
This company
38.2%
Market median
+81% vs market
20222025
Return on equity
2.9%
This company
18.4%
Market median
-84% vs market
20222025
Net profit margin
2.0%
This company
8.1%
Market median
-75% vs market
20222025
Asset turnover
1.00×
This company
1.12×
Market median
+11% vs market
20222025
Debt / equity
0.45×
This company
0.62×
Market median
+27% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-11-12 – 2022-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dylan & Sara AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sara Asadi | Deputy Board Member | 0 companies |
| John Dylan Mäenpää | Board of Directors | 0 companies |